Serum Chromium, Nickel, and Magnesium in Type 2 Diabetic Periodontitis
Evaluation of Serum Chromium, Nickel, and Magnesium Levels in Patients With Type 2 Diabetes Mellitus and Periodontitis: A Cross-Sectional Study
1 other identifier
observational
74
1 country
1
Brief Summary
Periodontitis is a chronic immunoinflammatory disease that has been increasingly associated with systemic conditions, particularly type 2 diabetes mellitus (T2DM). Trace elements such as chromium (Cr), magnesium (Mg), and nickel (Ni) play important roles in metabolic regulation, insulin signaling, inflammatory responses, and tissue integrity. Alterations in the serum levels of these elements have been reported in T2DM; however, their relationship with periodontal status remains poorly understood. This cross-sectional observational study aims to evaluate serum Cr, Mg, and Ni levels in individuals with T2DM and chronic periodontitis and to investigate their potential associations with periodontal clinical parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 24, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedJanuary 8, 2026
December 1, 2025
4 months
December 24, 2025
December 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum levels of chromium, magnesium, and nickel
The primary outcome is the assessment of fasting serum chromium, magnesium, and nickel concentrations measured using atomic absorption spectrometry in individuals with type 2 diabetes mellitus with and without chronic periodontitis, and systemically healthy controls.
Single time point (cross-sectional assessment)
Secondary Outcomes (3)
Periodontal clinical parameters
Single time point
Association between serum trace element levels and periodontal parameters
Single time point
Effect of glycemic control on serum trace element levels
Single time point
Study Arms (4)
Control group
Systemically and periodontally healthy individuals.
Periodontitis group
Systemically healthy individuals with Stage II, Grade B periodontitis.
Controlled T2DM with periodontitis group
Individuals with HbA1c \< 7.0 and Stage II, Grade B periodontitis.
Uncontrolled T2DM with periodontitis group
Individuals with HbA1c ≥ 7.0 and Stage II, Grade C periodontitis.
Interventions
Participants were not assigned to any therapeutic or preventive intervention. The study involved periodontal examination and blood sample collection for serum trace element analysis only.
Eligibility Criteria
The study population consists of adult individuals aged 18 years and older who were systemically evaluated at the Department of Endocrinology and Metabolism and subsequently referred for periodontal examination. Participants include systemically and periodontally healthy individuals as well as patients diagnosed with chronic periodontitis, with or without type 2 diabetes mellitus. Eligible participants were allocated into study groups based on periodontal status and glycemic control.
You may qualify if:
- Adults aged ≥18 years
- Having at least 20 natural teeth, excluding third molars
- Diagnosed with type 2 diabetes mellitus or systemically healthy, according to group allocation
- Willingness to participate in the study and provision of written informed consent
You may not qualify if:
- Presence of systemic diseases other than type 2 diabetes mellitus (e.g., renal or hepatic failure, cardiovascular disease, organ transplantation, or current or previous cancer treatment)
- Use of antibiotics, non-steroidal anti-inflammatory drugs, corticosteroids, immunosuppressive drugs, calcium channel blockers, beta blockers, oral contraceptives, or anticoagulants within the last 3 months
- History of non-surgical periodontal treatment within the last 6 months or periodontal surgery within the last 12 months
- Pregnancy or lactation
- Body mass index (BMI) ≥ 30 kg/m²
- Current smoking or alcohol consumption
- Use of vitamin, mineral, or antioxidant supplements within the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaraş Sütçü İmam University
Kahramanmaraş, Turkey (Türkiye)
Related Publications (2)
Titcomb TJ, Liu B, Lehmler HJ, Snetselaar LG, Bao W. Environmental Nickel Exposure and Diabetes in a Nationally Representative Sample of US Adults. Expo Health. 2021 Dec;13(4):697-704. doi: 10.1007/s12403-021-00413-9. Epub 2021 Sep 29.
PMID: 35685677RESULTToaima DN, Abdel-Maksoud KS, Atef HM, Salah NY. Magnesium, fibrinolysis and clotting interplay among children and adolescents with type 1 diabetes mellitus; potential mediators of diabetic microangiopathy. Nutr Diabetes. 2025 Apr 1;15(1):13. doi: 10.1038/s41387-025-00368-9.
PMID: 40169565RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
esra bozkurt
Kahramanmaras Sutcu Imam University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 24, 2025
First Posted
January 8, 2026
Study Start
July 1, 2025
Primary Completion
October 30, 2025
Study Completion
October 30, 2025
Last Updated
January 8, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers, as there is no predefined data-sharing plan in the study protocol or informed consent, and all data will be used solely for the purposes of the present research in accordance with ethical approval and data protection regulations.